{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:28:01Z","timestamp":1782390481539,"version":"3.54.5"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Exeltis France","award":["2015-005690-20"],"award-info":[{"award-number":["2015-005690-20"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006020","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T13:27:43Z","timestamp":1516282063000},"page":"e0006020","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":77,"title":["Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers"],"prefix":"10.1371","volume":"12","author":[{"given":"Jose","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosa","family":"Ballester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Maria","family":"Antonijoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Gich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Colli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-1211","authenticated-orcid":true,"given":"Alejandro J.","family":"Krolewiecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pt.2014.07.005","article-title":"Ivermectin: panacea for resource-poor communities?","volume":"30","author":"S Omura","year":"2014","journal-title":"Trends Parasitol"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"e0005419","DOI":"10.1371\/journal.pntd.0005419","article-title":"Neglected tropical diseases: A proxy for equitable development and shared prosperity","volume":"11","author":"D Engels","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1186\/s40249-016-0160-7","article-title":"Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results","volume":"5","author":"AH Tekle","year":"2016","journal-title":"Infectious Diseases of Poverty"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12936-017-1801-4","article-title":"Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety","volume":"16","author":"C Chaccour","year":"2017","journal-title":"Malar J"},{"issue":"9070","key":"ref5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"J Gardon","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.pt.2017.02.004","article-title":"Ivermectin\u2014Old Drug, New Tricks?","volume":"33","author":"R Laing","year":"2017","journal-title":"Trends Parasitol"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1086\/657310","article-title":"Albendazole and mebendazole administered alone or in combination with ivermectin against Trichuris trichiura: a randomized controlled trial","volume":"51","author":"S Knopp","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ref8","first-page":"35","article-title":"A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp","volume":"81","author":"VY Belizario","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.parepi.2016.02.004","article-title":"Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of Trichuris trichiura","volume":"1","author":"HC Turner","year":"2016","journal-title":"Parasite Epidemiol Control"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpara.2009.11.001","article-title":"Unresolved issues in anthelmintic pharmacology for helminthiases of humans","volume":"40","author":"TG Geary","year":"2010","journal-title":"Int J Parasitol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.vetpar.2017.03.026","article-title":"Managing anthelmintic resistance in Parascaris spp.: A modelling exercise","volume":"240","author":"DM Leathwick","year":"2017","journal-title":"Vet Parasitol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12936-017-1835-7","article-title":"Drug-based vector control: a potential new paradigm","volume":"16","author":"P Alonso","year":"2017","journal-title":"Malar J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1475-2875-11-381","article-title":"Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae","volume":"11","author":"KC Kobylinski","year":"2012","journal-title":"Malar J"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The pharmacokinetics and interactions of ivermectin in humans\u2014a mini-review","volume":"10","author":"A Gonzalez Canga","year":"2008","journal-title":"AAPS J"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF00637608","article-title":"The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution","volume":"35","author":"G Edwards","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/009127002401382731","article-title":"Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects","volume":"42","author":"CA Guzzo","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2350-11-111","article-title":"Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?","volume":"11","author":"W Kudzi","year":"2010","journal-title":"BMC Med Genet"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40262-016-0467-3","article-title":"Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review","volume":"56","author":"L Verrest","year":"2017","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"ref19","first-page":"133","article-title":"The effects on longevity and fecundity of Glossina tachinoides after feeding on pigs treated with ivermectin","volume":"68","author":"P Van den Bossche","year":"1988","journal-title":"Ann Soc Belg Med Trop"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12936-016-1540-y","article-title":"Filling gaps on ivermectin knowledge: effects on the survival and reproduction of Anopheles aquasalis, a Latin American malaria vector","volume":"15","author":"VS Sampaio","year":"2016","journal-title":"Malar J"},{"issue":"3\u20134","key":"ref21","first-page":"361","article-title":"Ivermectin dose assessment without weighing scales","volume":"71","author":"ND Alexander","year":"1993","journal-title":"Bull World Health Organ"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12916-016-0701-8","article-title":"An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia","volume":"14","author":"R Leang","year":"2016","journal-title":"BMC Med"},{"key":"ref23","unstructured":"Abbott Laborat\u00f3rios do Brasil Ltda. Modelo de bula para os profesionais de sa\u00fade 2013 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dam.abbott.com\/pt-br\/documents\/pdfs\/nossas-bulas\/r\/REVECTINA%20-%20(bula%20do%20paciente).pdf\" xlink:type=\"simple\">http:\/\/dam.abbott.com\/pt-br\/documents\/pdfs\/nossas-bulas\/r\/REVECTINA%20-%20(bula%20do%20paciente).pdf<\/ext-link>."},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4269\/ajtmh.2007.76.1153","article-title":"Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers","volume":"76","author":"GW Amsden","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref25","article-title":"Sample size and power","author":"S Bolton","year":"1990","journal-title":"Pharmaceutical statistics"},{"key":"ref26","unstructured":"Guideline on bioanalytical method validation (EMEA\/CHMP\/EWP\/192217\/2009, 21 July 2011) Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdfAccessed\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/08\/WC500109686.pdfAccessed<\/ext-link> 03 November 2015."},{"key":"ref27","unstructured":"Guide for validation of analytical and bioanalytical methods Resolution -RDC# 27 of 17\/may\/2012 of the Ag\u00e9ncia National de Vigil\u00e1ncia Sanit\u00e0ria ANVISA Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/portal.anvisa.gov.br\/documents\/33880\/2568070\/rdc0027_17_05_2012.pdf\/c6edeb56-200d-4482-8a19-99fa11c33fd3Accessed\" xlink:type=\"simple\">http:\/\/portal.anvisa.gov.br\/documents\/33880\/2568070\/rdc0027_17_05_2012.pdf\/c6edeb56-200d-4482-8a19-99fa11c33fd3Accessed<\/ext-link> 03 November 2015"},{"key":"ref28","unstructured":"World Medical Association. Declaration of Helsinki (Last Revision 9st: Brazil, October 2013) Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/Accessed\" xlink:type=\"simple\">https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/Accessed<\/ext-link> 22 February 2016."},{"key":"ref29","unstructured":"ICH Topic E6 (R1). Guideline for Good Clinical Practice Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ich.org\/products\/guidelines\/efficacy\/efficacy-single\/article\/good-clinical-practice.html\" xlink:type=\"simple\">http:\/\/www.ich.org\/products\/guidelines\/efficacy\/efficacy-single\/article\/good-clinical-practice.html<\/ext-link>. Accessed 22 February 2016."},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12936-017-1830-z","article-title":"Upon entering an age of global ivermectin-based integrated mass drug administration for neglected tropical diseases and malaria","volume":"16","author":"FO Richards Jr.","year":"2017","journal-title":"Malar J"},{"issue":"24","key":"ref31","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass Drug Administration for Scabies Control in a Population with Endemic Disease","volume":"373","author":"L Romani","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0035-9203(99)90305-X","article-title":"The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients","volume":"93","author":"K Awadzi","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1086\/657064","article-title":"Higher-dose, more frequent treatment of Wuchereria bancrofti","volume":"51","author":"JW Kazura","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ref34","first-page":"131","article-title":"The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin","volume":"46","author":"K Awadzi","year":"1995","journal-title":"Trop Med Parasitol"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002280050131","article-title":"Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus","volume":"50","author":"OZ Baraka","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"ref36","first-page":"609","article-title":"Determination of ivermectin in human plasma by high-performance liquid chromatography","volume":"43","author":"DR Krishna","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"ref37","first-page":"203","article-title":"Human pharmacokinetics of orally taken ivermectin","volume":"17","author":"RB Long QC","year":"2001","journal-title":"Chin J Clin"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Vanapalli SR CY, Ellingrod VL, Kitzman D, Lee DS, Hohl RJ. Orange juice decreases the oral bioavailability of ivermectin in healthy volunteers. PharmD, Theravance Inc; University of Iowa, South San Francisco, CA2003.","DOI":"10.1016\/S0009-9236(03)90702-8"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1038\/s41598-017-08906-x","article-title":"Cytochrome P450\/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae","volume":"7","author":"CJ Chaccour","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.2196\/resprot.6617","article-title":"Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya","volume":"5","author":"MR Smit","year":"2016","journal-title":"JMIR Res Protoc"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T10:32:00Z","timestamp":1570617120000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006020"}},"subtitle":[],"editor":[{"given":"Roger K.","family":"Prichard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006020","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]}}}